IQVIA predicts robust pharma growth over next five years

29 January 2019
pills_drugs_capsules_pharma_big

A new report from industry analyst IQVIA finds that global drug spending reached $1.2 trillion in 2018, and that total spending on medicines is expected to top $1.5 trillion by 2023, up 50% from 2016.

The  study found however that annual growth is likely to slow to between 3% and 6% on an annual compound basis, compared to 6.3% over the past five years, with key markets driving growth likely to be the USA and emerging markets.

The report, titled “Global Use of Medicine in 2019 and Outlook to 2023: Forecasts and Areas to Watch,” also analyzes several key healthcare areas and produces predictions to monitor in coming years.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical